Purple Biotech Ltd
Net Cash Flow Breakdown
Total Cash from Operations: $98.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $156.0K | 0.2% |
| Other Investing | $49.4M | 50.3% |
| Working Capital | $28.1M | 28.6% |
| Other | $13.8M | 14.0% |
| Net Cash Flow | $6.8M | 6.9% |
Net Cash Flow Breakdown
Total Cash from Operations: $98.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $156.0K | 0.2% |
| Other Investing | $49.4M | 50.3% |
| Working Capital | $28.1M | 28.6% |
| Other | $13.8M | 14.0% |
| Net Cash Flow | $6.8M | 6.9% |